Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2006-07-13 / Immunobiology 2006;211(6-8):677-85The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
/in Glioblastoma, International Publications /von 2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
/in Glioblastoma, International Publications /von 2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution